129 related articles for article (PubMed ID: 10593468)
1. Stereoselective pharmacokinetics of ketorolac in children, adolescents and adults.
Hamunen K; Maunuksela EL; Sarvela J; Bullingham RE; Olkkola KT
Acta Anaesthesiol Scand; 1999 Nov; 43(10):1041-6. PubMed ID: 10593468
[TBL] [Abstract][Full Text] [Related]
2. Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children.
Kauffman RE; Lieh-Lai MW; Uy HG; Aravind MK
Clin Pharmacol Ther; 1999 Apr; 65(4):382-8. PubMed ID: 10223774
[TBL] [Abstract][Full Text] [Related]
3. Enantiomer-specific ketorolac pharmacokinetics in young women, including pregnancy and postpartum period.
Kulo A; Smits A; Maleškić S; Van de Velde M; Van Calsteren K; De Hoon J; Verbesselt R; Deprest J; Allegaert K
Bosn J Basic Med Sci; 2017 Feb; 17(1):54-60. PubMed ID: 27968707
[TBL] [Abstract][Full Text] [Related]
4. Ketorolac tromethamine: stereo-specific pharmacokinetics and single-dose use in postoperative infants aged 2-6 months.
Lynn AM; Bradford H; Kantor ED; Andrew M; Vicini P; Anderson GD
Paediatr Anaesth; 2011 Mar; 21(3):325-34. PubMed ID: 21199130
[TBL] [Abstract][Full Text] [Related]
5. Age-stratified pharmacokinetics of ketorolac tromethamine in pediatric surgical patients.
Dsida RM; Wheeler M; Birmingham PK; Wang Z; Heffner CL; Coté CJ; Avram MJ
Anesth Analg; 2002 Feb; 94(2):266-70, table of contents. PubMed ID: 11812682
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of ketorolac after single postoperative intranasal administration in adolescent patients.
Drover DR; Hammer GB; Anderson BJ
Anesth Analg; 2012 Jun; 114(6):1270-6. PubMed ID: 22467894
[TBL] [Abstract][Full Text] [Related]
7. Postoperative ketorolac tromethamine use in infants aged 6-18 months: the effect on morphine usage, safety assessment, and stereo-specific pharmacokinetics.
Lynn AM; Bradford H; Kantor ED; Seng KY; Salinger DH; Chen J; Ellenbogen RG; Vicini P; Anderson GD
Anesth Analg; 2007 May; 104(5):1040-51, tables of contents. PubMed ID: 17456651
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of ketorolac enantiomers following intramuscular administration of the racemate.
Hayball PJ; Wrobel J; Tamblyn JG; Nation RL
Br J Clin Pharmacol; 1994 Jan; 37(1):75-8. PubMed ID: 8148223
[TBL] [Abstract][Full Text] [Related]
9. Ketorolac for postoperative pain management in children.
Forrest JB; Heitlinger EL; Revell S
Drug Saf; 1997 May; 16(5):309-29. PubMed ID: 9187531
[TBL] [Abstract][Full Text] [Related]
10. Impact of enantiomer-specific changes in pharmacokinetics between infants and adults on the target concentration of racemic ketorolac: A pooled analysis.
Cloesmeijer ME; van Esdonk MJ; Lynn AM; Smits A; Tibboel D; Daali Y; Olkkola KT; Allegaert K; Mian P
Br J Clin Pharmacol; 2021 Mar; 87(3):1443-1454. PubMed ID: 32901947
[TBL] [Abstract][Full Text] [Related]
11. Comparison of intranasal ketorolac tromethamine pharmacokinetics in younger and older adults.
Bullingham R; Juan A
Drugs Aging; 2012 Nov; 29(11):899-904. PubMed ID: 23143939
[TBL] [Abstract][Full Text] [Related]
12. Development of an enantiomer selective microsampling assay for the quantification of ketorolac suitable for paediatric pharmacokinetic studies.
Mohammed BS; Engelhardt T; Cameron GA; Hawwa AF; Helms PJ; McLay JS
Biopharm Drug Dispos; 2013 Oct; 34(7):377-86. PubMed ID: 24251328
[TBL] [Abstract][Full Text] [Related]
13. Body weight, gender and pregnancy affect enantiomer-specific ketorolac pharmacokinetics.
Välitalo PA; Kemppainen H; Kulo A; Smits A; van Calsteren K; Olkkola KT; de Hoon J; Knibbe CAJ; Allegaert K
Br J Clin Pharmacol; 2017 Sep; 83(9):1966-1975. PubMed ID: 28429492
[TBL] [Abstract][Full Text] [Related]
14. A randomized comparison of ketorolac tromethamine and morphine for postoperative analgesia in critically ill children.
Lieh-Lai MW; Kauffman RE; Uy HG; Danjin M; Simpson PM
Crit Care Med; 1999 Dec; 27(12):2786-91. PubMed ID: 10628627
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of ketorolac after intravenous and oral single dose administration in dogs.
Pasloske K; Renaud R; Burger J; Conlon P
J Vet Pharmacol Ther; 1999 Oct; 22(5):314-9. PubMed ID: 10597535
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult volunteers.
Galán-Herrera JF; Poo JL; Maya-Barrios JA; de Lago A; Oliva I; González-de la Parra M; Jiménez P; López-Bojórquez E; Burke-Fraga V; Namur S
Clin Ther; 2008 Sep; 30(9):1667-74. PubMed ID: 18840372
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of postoperative intravenous ketorolac tromethamine in children.
Olkkola KT; Maunuksela EL
Br J Clin Pharmacol; 1991 Feb; 31(2):182-4. PubMed ID: 2049235
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Pharmacokinetics of Ketorolac Tromethamine After Continuous Subcutaneous Infusion and Repeat Intramuscular Bolus Injections in Healthy Adult Subjects.
Burdick M; Mamelok R; Hurliman M; Dupuis M; Xie Y; Grenier J; Sheldon C; Gartner M; Noymer P
Clin Pharmacol Drug Dev; 2017 Jul; 6(4):343-349. PubMed ID: 27739232
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients.
Solomon KD; Donnenfeld ED; Raizman M; Sandoval HP; Stern K; VanDenburgh A; Cheetham JK; Schiffman R;
J Cataract Refract Surg; 2004 Aug; 30(8):1653-60. PubMed ID: 15313287
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration.
Jung D; Mroszczak E; Bynum L
Eur J Clin Pharmacol; 1988; 35(4):423-5. PubMed ID: 3264245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
